market - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

News

PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments

New facilities offer innovative equipment and increased capacity to bring highly potent oncology therapies to market PHILADELPHIA – July 27, 2022 – PCI Pharma Ser...

27 July 2022 News cancer | clinical

Continue Reading →

Volume 13 Issue 4

Balancing The Complexity-efficiency Equation in a Fast-changing Prefilled Syringe Packaging Market

Marcelo Cruz, Director of Business Development and Marketing at Tjoapack, discusses the fast-changing pharmaceutical market landscape and explores the latest trends ...

24 November 2021 Volume 13 Issue 4 companies | market

Continue Reading →

News

Korea finished drug market growth driven by generics

FDF launches at CPhI Korea as country set to become regional hub The Korean pharma market is experiencing significant growth in finished drug products, according to ...

10 July 2018 News driven | drug

Continue Reading →

News

TraceLink Grows Market Position in DACH Region by 215%

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better pati...

12 March 2018 News DACH | market

Continue Reading →

News

Pertinax Pharma further expands into global woundcare markets with appointment of Business Developmemt Manager

Paul Williams brings established international sales expertise to the company’s commercial growth strategy Pertinax Pharma announces that Paul Williams has been...

27 February 2018 News global | market

Continue Reading →

News

Japanese pharma – no longer ‘lost in translation’

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increa...

15 January 2018 News biosimilars | CPhI

Continue Reading →

Volume 9 Issue 4

Expanding Markets: Where Next? A Regional Regulatory Roundup

Globalisation and the growing efforts to standardise submission requirements and formats internationally continue to open up new markets for life sciences companies....

4 January 2018 Volume 9 Issue 4 expanding | market

Continue Reading →

News

Singapore’s pharmaceutical market value to reach $1.15 billion by 2021, says GlobalData

Singapore’s pharmaceutical market is expected to expand from $903 million in 2016 to $1.15 billion by 2021, according to GlobalData, a leading data and analytics com...

17 November 2017 News biomedical | destination

Continue Reading →

News

CPhI Global Pharma Index: India’s reputation improving and ranks third most competitive nation

CPhI & P-MEC India – organised by UBM – is set to welcome more than 50,000 attendees as the CPhI Global Pharma Index shows the country’s efforts t...

10 November 2017 News competitive | CPhI

Continue Reading →

Special Feauture v4i3

Product Liability: Navigating a Restrictive Market

Insurers are facing a growing number of product liability claims in what is becoming an increasingly litigious environment in the UK and Europe. Stricter regulat...

26 September 2012 Special Feauture v4i3 | Volume 4 Issue 3 liability | market

Continue Reading →

Future-ready ADCs – advanced vial solutions for superior stability and performance

Alternative Drug Delivery Routes: Opportunities, Challenges, and How to Overcome Them

Bridging the gap between R&D and GMP

Current Edition

Current Edition

Subsection - CDMO

Subsection - Injectables

Subsection - Neurodegenerative Diseases

Subsection - Nasal & Pulmonary

PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments

Balancing The Complexity-efficiency Equation in a Fast-changing Prefilled Syringe Packaging Market

Korea finished drug market growth driven by generics

TraceLink Grows Market Position in DACH Region by 215%

Pertinax Pharma further expands into global woundcare markets with appointment of Business Developmemt Manager

Japanese pharma – no longer ‘lost in translation’

Expanding Markets: Where Next? A Regional Regulatory Roundup

Singapore’s pharmaceutical market value to reach $1.15 billion by 2021, says GlobalData

CPhI Global Pharma Index: India’s reputation improving and ranks third most competitive nation

Product Liability: Navigating a Restrictive Market

International Pharmaceutical Industry